{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:21:31Z","timestamp":1790785291890,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T00:00:00Z","timestamp":1586736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","award":["18-IIA-407"],"award-info":[{"award-number":["18-IIA-407"]}],"id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","award":["2313"],"award-info":[{"award-number":["2313"]}],"id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["479769"],"award-info":[{"award-number":["479769"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01-NS099114"],"award-info":[{"award-number":["P01-NS099114"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01-NS084974"],"award-info":[{"award-number":["P01-NS084974"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS088689"],"award-info":[{"award-number":["R01-NS088689"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01-NS099114"],"award-info":[{"award-number":["P01-NS099114"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS27036"],"award-info":[{"award-number":["R01-NS27036"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS087227"],"award-info":[{"award-number":["R01-NS087227"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01-NS27036"],"award-info":[{"award-number":["R01-NS27036"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41593-020-0619-5","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T12:02:48Z","timestamp":1586779368000},"page":"615-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":215,"title":["Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72"],"prefix":"10.1038","volume":"23","author":[{"given":"Qiang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-2627","authenticated-orcid":false,"given":"Tania F.","family":"Gendron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"McAlonis-Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Diaz Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somasish","family":"Ghosh Dastidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"La Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ravits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Da Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-8322","authenticated-orcid":false,"given":"Clotilde","family":"Lagier-Tourenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1934-3682","authenticated-orcid":false,"given":"Don W.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,13]]},"reference":[{"key":"619_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245\u2013256 (2011).","journal-title":"Neuron"},{"key":"619_CR2","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"619_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/bioinformatics\/bts725","volume":"29","author":"TP Levine","year":"2013","unstructured":"Levine, T. P., Daniels, R. D., Gatta, A. T., Wong, L. H. & Hayes, M. J. The product of C9orf72, a gene strongly implicated in neurodegeneration, is structurally related to DENN Rab-GEFs. Bioinformatics 29, 499\u2013503 (2013).","journal-title":"Bioinformatics"},{"key":"619_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1073\/pnas.1013343108","volume":"108","author":"T Zu","year":"2011","unstructured":"Zu, T. et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl Acad. Sci. USA 108, 260\u2013265 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"619_CR5","doi-asserted-by":"publisher","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","volume":"110","author":"T Zu","year":"2013","unstructured":"Zu, T. et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl Acad. Sci. USA 110, E4968\u2013E4977 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"619_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","volume":"126","author":"K Mori","year":"2013","unstructured":"Mori, K. et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126, 881\u2013893 (2013).","journal-title":"Acta Neuropathol."},{"key":"619_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","volume":"77","author":"PE Ash","year":"2013","unstructured":"Ash, P. E. et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS. Neuron 77, 639\u2013646 (2013).","journal-title":"Neuron"},{"key":"619_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra, R. & Isaacs, A. M. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat. Rev. Neurol. 14, 544\u2013558 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"619_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00401-015-1476-2","volume":"130","author":"IR Mackenzie","year":"2015","unstructured":"Mackenzie, I. R. et al. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Acta Neuropathol. 130, 845\u2013861 (2015).","journal-title":"Acta Neuropathol."},{"key":"619_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41593-017-0066-0","volume":"21","author":"N Li","year":"2018","unstructured":"Li, N. & Lagier-Tourenne, C. Nuclear pores: the gate to neurodegeneration. Nat. Neurosci. 21, 156\u2013158 (2018).","journal-title":"Nat. Neurosci."},{"key":"619_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00401-017-1793-8","volume":"135","author":"S Saberi","year":"2018","unstructured":"Saberi, S. et al. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Acta Neuropathol. 135, 459\u2013474 (2018).","journal-title":"Acta Neuropathol."},{"key":"619_CR12","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","volume":"126","author":"IR Mackenzie","year":"2013","unstructured":"Mackenzie, I. R. et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 126, 859\u2013879 (2013).","journal-title":"Acta Neuropathol."},{"key":"619_CR13","doi-asserted-by":"publisher","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","volume":"110","author":"C Lagier-Tourenne","year":"2013","unstructured":"Lagier-Tourenne, C. et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc. Natl Acad. Sci. USA 110, E4530\u2013E4539 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"619_CR14","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1093\/hmg\/ddr299","volume":"20","author":"M Wojciechowska","year":"2011","unstructured":"Wojciechowska, M. & Krzyzosiak, W. J. Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum. Mol. Genet. 20, 3811\u20133821 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"619_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn.2016.38","volume":"17","author":"AR Haeusler","year":"2016","unstructured":"Haeusler, A. R., Donnelly, C. J. & Rothstein, J. D. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 17, 383\u2013395 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"619_CR16","doi-asserted-by":"publisher","first-page":"e08881","DOI":"10.7554\/eLife.08881","volume":"4","author":"AS Burguete","year":"2015","unstructured":"Burguete, A. S. et al. GGGGCC microsatellite RNA is neuritically localized, induces branching defects, and perturbs transport granule function. eLife 4, e08881 (2015).","journal-title":"eLife"},{"key":"619_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","volume":"90","author":"J Jiang","year":"2016","unstructured":"Jiang, J. et al. Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs. Neuron 90, 535\u2013550 (2016).","journal-title":"Neuron"},{"key":"619_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","volume":"90","author":"Y Liu","year":"2016","unstructured":"Liu, Y. et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD. Neuron 90, 521\u2013534 (2016).","journal-title":"Neuron"},{"key":"619_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aaa9344","volume":"348","author":"J Chew","year":"2015","unstructured":"Chew, J. et al. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348, 1151\u20131154 (2015).","journal-title":"Science"},{"key":"619_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","volume":"126","author":"VV Belzil","year":"2013","unstructured":"Belzil, V. V. et al. Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 126, 895\u2013905 (2013).","journal-title":"Acta Neuropathol."},{"key":"619_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","volume":"80","author":"CJ Donnelly","year":"2013","unstructured":"Donnelly, C. J. et al. RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80, 415\u2013428 (2013).","journal-title":"Neuron"},{"key":"619_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-018-0579-0","volume":"6","author":"P Frick","year":"2018","unstructured":"Frick, P. et al. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers. Acta Neuropathol. Commun. 6, 72 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"619_CR23","doi-asserted-by":"publisher","first-page":"1779 e1775","DOI":"10.1016\/j.neurobiolaging.2014.01.016","volume":"35","author":"AJ Waite","year":"2014","unstructured":"Waite, A. J. et al. Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol. Aging 35, 1779 e1775\u20131779 e1713 (2014).","journal-title":"Neurobiol. Aging"},{"key":"619_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ajhg.2013.04.017","volume":"92","author":"Z Xi","year":"2013","unstructured":"Xi, Z. et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am. J. Hum. Genet. 92, 981\u2013989 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"619_CR25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-015-1401-8","volume":"129","author":"Z Xi","year":"2015","unstructured":"Xi, Z. et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 129, 715\u2013727 (2015).","journal-title":"Acta Neuropathol."},{"key":"619_CR26","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.23946","volume":"74","author":"S Ciura","year":"2013","unstructured":"Ciura, S. et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann. Neurol. 74, 180\u2013187 (2013).","journal-title":"Ann. Neurol."},{"key":"619_CR27","doi-asserted-by":"publisher","first-page":"e83450","DOI":"10.1371\/journal.pone.0083450","volume":"8","author":"M Therrien","year":"2013","unstructured":"Therrien, M., Rouleau, G. A., Dion, P. A. & Parker, J. A. Deletion of C9ORF72 results in motor neuron degeneration and stress sensitivity in C. elegans. PLoS ONE 8, e83450 (2013).","journal-title":"PLoS ONE"},{"key":"619_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","volume":"351","author":"JG O\u2019Rourke","year":"2016","unstructured":"O\u2019Rourke, J. G. et al. C9orf72 is required for proper macrophage and microglial function in mice. Science 351, 1324\u20131329 (2016).","journal-title":"Science"},{"key":"619_CR29","doi-asserted-by":"publisher","first-page":"23204","DOI":"10.1038\/srep23204","volume":"6","author":"A Atanasio","year":"2016","unstructured":"Atanasio, A. et al. C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci. Rep. 6, 23204 (2016).","journal-title":"Sci. Rep."},{"key":"619_CR30","doi-asserted-by":"publisher","first-page":"e1006443","DOI":"10.1371\/journal.pgen.1006443","volume":"12","author":"J Ugolino","year":"2016","unstructured":"Ugolino, J. et al. Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling. PLoS Genet. 12, e1006443 (2016).","journal-title":"PLoS Genet."},{"key":"619_CR31","doi-asserted-by":"publisher","first-page":"347ra393","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry, A. et al. Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci. Transl. Med. 8, 347ra393 (2016).","journal-title":"Sci. Transl. Med."},{"key":"619_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-016-0324-5","volume":"4","author":"PM Sullivan","year":"2016","unstructured":"Sullivan, P. M. et al. The ALS\/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. Acta Neuropathol. Commun. 4, 51 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"619_CR33","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/ana.24453","volume":"78","author":"M Koppers","year":"2015","unstructured":"Koppers, M. et al. C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits. Ann. Neurol. 78, 426\u2013438 (2015).","journal-title":"Ann. Neurol."},{"key":"619_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","volume":"24","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat. Med. 24, 313\u2013325 (2018).","journal-title":"Nat. Med."},{"key":"619_CR35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.15252\/embj.201593350","volume":"35","author":"C Sellier","year":"2016","unstructured":"Sellier, C. et al. Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J. 35, 1276\u20131297 (2016).","journal-title":"EMBO J."},{"key":"619_CR36","doi-asserted-by":"publisher","first-page":"e1601167","DOI":"10.1126\/sciadv.1601167","volume":"2","author":"M Yang","year":"2016","unstructured":"Yang, M. et al. A C9ORF72\/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy. Sci. Adv. 2, e1601167 (2016).","journal-title":"Sci. Adv."},{"key":"619_CR37","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.15252\/embj.201694401","volume":"35","author":"CP Webster","year":"2016","unstructured":"Webster, C. P. et al. The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J. 35, 1656\u20131676 (2016).","journal-title":"EMBO J."},{"key":"619_CR38","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1101\/gad.313932.118","volume":"32","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. The C9orf72-interacting protein Smcr8 is a negative regulator of autoimmunity and lysosomal exocytosis. Genes Dev. 32, 929\u2013943 (2018).","journal-title":"Genes Dev."},{"key":"619_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15548627.2019.1569441","volume":"15","author":"WY Ho","year":"2019","unstructured":"Ho, W. Y. et al. The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy. Autophagy 15, 827\u2013842 (2019).","journal-title":"Autophagy"},{"key":"619_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-014-1286-y","volume":"128","author":"EY Liu","year":"2014","unstructured":"Liu, E. Y. et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS\/FTD. Acta Neuropathol. 128, 525\u2013541 (2014).","journal-title":"Acta Neuropathol."},{"key":"619_CR41","first-page":"283","volume":"3","author":"D Zhang","year":"2012","unstructured":"Zhang, D., Iyer, L. M., He, F. & Aravind, L. Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front. Genet. 3, 283 (2012).","journal-title":"Front. Genet."},{"key":"619_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuroimage.2014.12.003","volume":"107","author":"J Scholz","year":"2015","unstructured":"Scholz, J., Niibori, Y., W Frankland, P. & P Lerch, J. Rotarod training in mice is associated with changes in brain structure observable with multimodal MRI. Neuroimage 107, 182\u2013189 (2015).","journal-title":"Neuroimage"},{"key":"619_CR43","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4161\/auto.6259","volume":"4","author":"RA Nixon","year":"2008","unstructured":"Nixon, R. A., Yang, D. S. & Lee, J. H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4, 590\u2013599 (2008).","journal-title":"Autophagy"},{"key":"619_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","volume":"12","author":"DJ Klionsky","year":"2016","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1\u2013222 (2016).","journal-title":"Autophagy"},{"key":"619_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0092-8674(94)90396-4","volume":"79","author":"A Ciechanover","year":"1994","unstructured":"Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell 79, 13\u201321 (1994).","journal-title":"Cell"},{"key":"619_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05273-7","volume":"9","author":"M Chitiprolu","year":"2018","unstructured":"Chitiprolu, M. et al. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat. Commun. 9, 2794 (2018).","journal-title":"Nat. Commun."},{"key":"619_CR47","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s13311-019-00797-2","volume":"16","author":"J Jiang","year":"2019","unstructured":"Jiang, J. & Ravits, J. Pathogenic mechanisms and therapy development for C9orf72 amyotrophic lateral sclerosis\/frontotemporal dementia. Neurotherapeutics 16, 1115\u20131132 (2019).","journal-title":"Neurotherapeutics"},{"key":"619_CR48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3389\/fnins.2017.00442","volume":"11","author":"M Nassif","year":"2017","unstructured":"Nassif, M., Woehlbier, U. & Manque, P. A. The enigmatic role of C9ORF72 in autophagy. Front. Neurosci. 11, 442 (2017).","journal-title":"Front. Neurosci."},{"key":"619_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. Jr. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"619_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jneuroim.2019.01.004","volume":"328","author":"S Roy Sarkar","year":"2019","unstructured":"Roy Sarkar, S. & Banerjee, S. Gut microbiota in neurodegenerative disorders. J. Neuroimmunol. 328, 98\u2013104 (2019).","journal-title":"J. Neuroimmunol."},{"key":"619_CR51","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.aaf7791","volume":"353","author":"NJ Kramer","year":"2016","unstructured":"Kramer, N. J. et al. Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts. Science 353, 708\u2013712 (2016).","journal-title":"Science"},{"key":"619_CR52","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","volume":"83","author":"Z Su","year":"2014","unstructured":"Su, Z. et al. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS. Neuron 83, 1043\u20131050 (2014).","journal-title":"Neuron"},{"key":"619_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00401-015-1474-4","volume":"130","author":"TF Gendron","year":"2015","unstructured":"Gendron, T. F. et al. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol. 130, 559\u2013573 (2015).","journal-title":"Acta Neuropathol."},{"key":"619_CR54","doi-asserted-by":"publisher","first-page":"4657","DOI":"10.1523\/JNEUROSCI.1119-12.2013","volume":"33","author":"PA Parone","year":"2013","unstructured":"Parone, P. A. et al. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 33, 4657\u20134671 (2013).","journal-title":"J. Neurosci."},{"key":"619_CR55","doi-asserted-by":"publisher","first-page":"9230","DOI":"10.1073\/pnas.96.16.9230","volume":"96","author":"C Shao","year":"1999","unstructured":"Shao, C. et al. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc. Natl Acad. Sci. USA 96, 9230\u20139235 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"619_CR56","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1172\/JCI127695","volume":"129","author":"LL Jiang","year":"2019","unstructured":"Jiang, L. L. et al. Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment. J. Clin. Invest. 129, 3103\u20133120 (2019).","journal-title":"J. Clin. Invest."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41593-020-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41593-020-0619-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41593-020-0619-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T18:37:06Z","timestamp":1722710226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-020-0619-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,13]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1038\/s41593-020-0619-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737735007.793579145","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,13]]},"assertion":[{"value":"14 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.W.C. is a consultant for Ionis Pharmaceuticals. The other authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}